| Product Name | NebuSelect™ Recombinant Canine CD40/TNFRSF5, His-tag |
|---|---|
| Catalog Number | NBL-241414 |
| Alias/Synonyms | CD40/TNFRSF5 |
| Appearance | see COA |
| Molecule Weight | |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q7YRL5 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-241414-100ug | 100ug | Inquire | Inquire | |
| NBL-241414-1mg | 1mg | Inquire | Inquire | |
| NBL-241414-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Canine CD40/TNFRSF5, His-tag
Catalog#:
NBL-241414
Description:
NebuSelect™ Recombinant Canine CD40/TNFRSF5, His-tag(Cat#NBL-241414) is expressed in HEK293 with His tag at the C-Terminus.It contains Glu21-Ala194.
Species:
Canine
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 20.14 kDa. Due to glycosylation, the protein migrates to 30-40 kDa based on Bis-Tris PAGE result.
Target Name:
CD40/TNFRSF5
Target Information:
CD40 is a costimulatory protein found on antigen presenting cells and is required for their activation. The binding of CD154 (CD40L) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects.CD40 molecule is a potential target for cancer immunotherapy. There are number of completed and ongoing clinical trials where agonistic anti-CD40 monoclonal antibodies are employed to activate an anti-tumor T cell response via activation of dendritic cells.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.